MODERN POSSIBILITIES OF MEDICAL TREATMENT OF OVERACTIVE BLADDER IN WOMEN

Author:

Apolikhina I. A.1,Chochueva A. S.2,Saidova A. S.2,Gorbunova E. A.2

Affiliation:

1. Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare of the Russian Federation; First Moscow State Medical University, Ministry of Healthcare of the Russian Federation

2. Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare of the Russian Federation

Abstract

Overactive bladder (OAB) is a serious urination disorder which affects at least 17% of the population above 40 years old, of which 56% are women and 44% are men. M-cholinoblockers are the first line therapy and the main treatment for OAB. However, their side effects, along with low efficacy, force women to stop taking the drugs. Activation of beta-3-adrenergic receptors is known toreduce the tone of detrusor muscle in the bladder. This resulted in the invention of mirabegron (Mirabegron, Betmiga, Astellas Pharma Europe, Netherlands), the first drug of a new pharmacologic group (beta-3 adrenergic agonists) for the treatment of OAB. A selective beta-3 agonist, mirabegron has no side effects such as dry mouth, increased intraocular pressure or constipation. Numerous clinical studies demonstrated a reduction in the number of episodes of urinary incontinence and frequent urination in the mirabegron group compared to the placebo group.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference36 articles.

1. Abrams P. The standartisation of terminology of lower urinary tract function. Neurourol. and Urodyn, 2002, 21: 167-178.

2. Gadzhieva Zh.K. Narusheniya mocheispuskaniya: rukovodstvo. Pod red. Yu.G. Alyaeva. M.: GEOTAR-Media, 2010. 176 s.

3. Pushkar' D.Yu. Giperaktivnyi mochevoi puzyr' u zhenshchin. M.: MED press-inform, 2003. 160 s.

4. Dzhavad-Zade M.D., Derzhavin V.M., Vishnevskii E.L. Neirogennye disfunktsii mochevogo puzyrya. M.: Meditsina, 1989.

5. Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A populationbased prevalence study. BJU Int, 2001, 87: 760–6.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3